Germ cell tumor: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(58 intermediate revisions by one other user not shown)
Line 1: Line 1:
<div style="-webkit-user-select: none;">
{| class="infobox" style="position: fixed; top: 65%; right: 10px; margin: 0 0 0 0; border: 0; float: right;"
|-
|}
__NOTOC__
__NOTOC__
{{DiseaseDisorder infobox |
{{DiseaseDisorder infobox |
Line 16: Line 21:
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''


{{CMG}}
{{CMG}}; {{AE}} {{Hudakarman}}


{{SK}} Polyembryoma; Embryonal carcinoma
{{SK}} Polyembryoma;  


==[[Germ cell tumor overview|Overview]]==
==[[Germ cell tumor overview|Overview]]==
A germ-cell tumor (GCT) is a [[neoplasm]] derived from [[germ cells]] and it can be [[cancerous]] or [[benign.]] Based on their location, germ cell tumors can be classified into intragonadal ([[ovary]] and [[testis]]) or extragonadal ([[mediastinum]], [[brain]], [[retroperitoneum]], [[coccyx]]). [[Histologically]], Germ cell tumors can be classified as germinomatous/[[undifferentiated]] germ cell tumors which include, [[dysgerminoma]] and [[seminoma]]. and nongermminomatous/[[Differentiate|differentiated]] which include [[embryonic]] and extra-embryonic germ cell tumors. [[Embryonic]] germ cell tumors include [[teratoma]], and extraembryonic germ cell tumors include [[Choriocarcinoma]] and [[Yolk sac tumor]]. The name of a germ cell tumor came from the word (germinate), which means to begin to grow. During [[fetus]] development, germ cells migrate to become the [[Ovum|eggs]] in the [[ovary]] or the [[Sperm|sperms]] in the [[testicles]]. Germ cell tumors develop due to the abnormal growth of the germ cells in the [[ovary]], [[testis]], [[brain]], [[mediastinum]], [[coccyx]], or [[pelvis]]. [[World health organization|World health organization (WHO)]] classified germ cell [[tumors]] into 7 types based on [[histology]]. The cause of germ cell tumors development is not fully understood but some [[causes]] include, [[genetic mutations]], [[cryptorchidism]], [[undescended testes]], [[trauma]], [[mumps]], [[maternal]] [[estrogen]] exposure. Common [[risk factors]] include Caucasian [[race]],[[Family history]] or personal history of germ cell tumor, [[Klinefelter syndrome]]. Less common [[risk factors]] include,[[Infection|Infections]] such as [[HIV]], [[orchitis]], or history of [[trauma]]. [[Symptoms]] and [[signs]] of germ cell tumors depend on the type and location of the [[tumor]]. [[Symptoms]] of dysgerminoma can include, [[abdominal distention]], [[acute]]/ [[subacute]] [[abdominal pain]], [[menstrual irregularities]], and [[precocious puberty]]. [[Symptoms]] of [[seminoma]] include painless [[testicular mass]] with [[discomfort]], [[Back pain|back pain,]] [[abdominal discomfort]], or [[abdominal mass]]. Common [[complications]] of germ cell tumors include recurrence, [[lymph node]] [[metastasis]], distant [[metastasis]], and [[secondary]] [[malignancies]]. [[Laboratory|Lab]] findings include [[abnormal]] [[Tumor markers|serum tumor marker]] levels such as [[LDH]], [[HCG]] ([[seminoma]]), [[lactate dehydrogenase]] ([[LDH]]), [[human chorionic gonadotropin]] ([[HCG]]), [[CA-125]], and [[alpha-fetoprotein]] ([[AFP]]) ([[Ovarian Germ Cell Tumor|ovarian germ cell tumors]]), [[alpha fetoprotein]] ([[AFP]]) greater than 100 ng/ml ([[Endodermal sinus tumor|Endodermal sinus tumor)]]. [[CT]], [[MRI]], and [[ultrasound]] are used in combination with [[biopsy]] to distinguish between the types and subtypes of [[germ cell tumors]] and for [[diagnosis]] confirmation. [[Surgery]] along with [[chemotherapy]] are the mainstay of treatment depending on the [[Cancer staging|staging]] of the [[tumor]]. Depending on the type, location, and the extent of the [[tumor]] at the time of [[diagnosis]], the [[prognosis]] may vary.
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Gynecology]]
[[Category:Surgery]]


==[[Germ cell tumor classification|Classification]]==
==[[Germ cell tumor classification|Classification]]==
Germ cell tumors can be classified as follows:
=== '''Histologic-based classification''' ===
<br />{{familytree/start}}
{{familytree| | | | | | | | | | A01 | | | |A01=Germ cell tumors}}
{{familytree| | | | | |,|-|-|-|-|^|-|-|-|-|-|.| | | }}
{{familytree| | | | | B01 | | | | | | | | | B02 | | B01=Germinomatous/[[Undifferentiated]]/[[Immature]]|B02=Nongerminomatous/Differentiated/[[Mature]]}}
{{familytree| | |,|-|-|^|-|-|.| | | | | | | |!| | | |}}
{{familytree| | |!| | | | | |!| | | | | | | |!| | | |}}
{{familytree| | C01 | | | | C02 | | | | | | |!| | | | | C01=[[Dysgerminoma]]([[Ovary]])|C02=[[Seminoma]]([[Testis]])}}
{{familytree| | | | | | | | | | | | | | | | |!| | | | | | |}}
{{familytree| | | | |,|-|-|-|-|-|-|-|-|v|-|-|^|-|-|-|.| | |}}
{{familytree| | | | |!| | | | | | | | |!| | | | | | |!| | |}}
{{familytree| | | | D01 | | | | | | | D02 | | | | | D03 | | |D01=[[Embryonal carcinoma]]| D02=[[Embryonic]] [[tissue]]| D03=Extraembryonic tissue}}
{{familytree| | | | | | | | | | | | | |!| | | | |,|-|^|-|.| | |}}
{{familytree| | | | | | | | | | | | | E01 | | | E02 | | E03| | |E01=[[Teratoma]]|E02=[[Yolk sac tumor]]|E03=[[Choriocarcinoma]]}}
{{familytree/end}}
=== Location-based classification, regardless to the histologic findings: ===
<br />{{familytree/start}}
{{familytree| | | | | | | | | A01 | | | |A01=Germ cell tumors}}
{{familytree| | | | |,|-|-|-|-|^|-|-|-|-|-|.| | | }}
{{familytree| | | | B01 | | | | | | | | | B02 | | B01=Gonadal|B02=Extragonadal}}
{{familytree| | | | |!| | | | | | | | | | |!| | |}}
{{familytree| | | | C01 | | | | | | | | | C02| | | | |
C01=
Located in the gonads
*Ovary
*[[Testis]]|C02=
Located in the midline of the body including:
*CNS
*Mediastinum
*Retroperitoneum
*Coccyx}}
{{familytree| | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree/end}}
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF| Types}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Subtypes}}
! colspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Signs and Symptoms}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Histopathology}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF| Lab finding }}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF| Prognosis}}
|-
| rowspan="2;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Germinomatous
/Undifferentiated
<br />
| style="padding: 5px 5px; background: #F5F5F5;" |
Seminoma (Testis)
| style="padding: 5px 5px; background: #F5F5F5;" |
* Painless [[testicular mass]] with discomfort
*[[Back pain]]
*[[Abdominal discomfort]]
*[[Abdominal mass]].
| style="padding: 5px 5px; background: #F5F5F5;" |Gross: pale gray to yellow nodules that are uniform or slightly lobulated and often bulge from the cut surface
| style="padding: 5px 5px; background: #F5F5F5;" |
* Complete blood count and blood chemistry tests.
* Abnormal serum tumor marker levels ([[LDH]], [[HCG]]).
* CT: Metastases to the para-aortic, inguinal, or iliac lymph nodes. Visceral metastasis may also be seen.
* Pelvic MRI: may be diagnostic. multinodular tumors of uniform signal intensity
* Hypo- to isointense on T2-weighted images and inhomogenous enhancement on contrast enhanced T1-weighted images.
* Other diagnostic studies for seminoma include [[biopsy]], [[PET|FDG-PET scan]], and [[bone scan]].
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Prognosis]] of [[seminoma]] is good for all stages with greater than 90% cure rate.
* The International Germ Cell Cancer Consensus Group divides [[seminoma]] into two prognosis groups: good and intermediate.
* Common complications of [[seminoma]] include recurrence, [[lymph node]] [[metastasis]], distant [[metastasis]], and secondary [[malignancies]].
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
Dysgerminoma
(Ovary)
| style="padding: 5px 5px; background: #F5F5F5;" |
* Depend on the type of the [[tumor]] and its potential to produce [[hormonal]]<nowiki/>materials
*[[Abdominal pain]] or distention
*[[Menstrual irregularities]]
* Symptoms of [[virilization]]
* Rapidly growing [[abdominal]]/[[pelvic]] [[mass]]
*[[Acute abdominal pain]] from [[complications]] such as:
*[[Necrosis]]
*[[Capsule|Capsular]] distention
* [[Rupture]] or [[torsion]] and or simply they can be [[asymptomatic]].
| style="padding: 5px 5px; background: #F5F5F5;" |
*The majority of [[ovarian]] [[germ cell]][[tumors]] have a [[solid]] and [[cystic]] appearance with areas of [[hemorrhage]]<nowiki/>and [[necrosis]]
* A uniform “fried egg” appearance ([[dysgerminoma]])
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Beta-hCG]] to rule out [[pregnancy]] in women with abdominopelvic [[symptoms]]
*Cultures for [[gonorrhea]] and [[chlamydia]] and a wet mount in [[reproductive]] and [[sexually active]] women to role out and treat before [[surgery]] if [[positive]].
*[[Lactate dehydrogenase]] ([[LDH]]), [[alpha-fetoprotein]] ([[AFP]]), [[beta-human chorionic gonadotropin]] ([[beta-hCG]]) levels. If any levels are elevated, they may assist in [[diagnosis]] and/ or follow-up of women [[Diagnosis|diagnosed]] with [[malignant]] [[Ovarian germ cell tumor|ovarian GCTs]].
*[[Inhibin A]] and B
*[[CA-125|Cancer antigen 125]] ([[CA-125]]) - For epithelial tumors
*[[Ultrasound]]: [[Dysgerminoma]] often appears as a [[Echogenicity|hypoechoic]] [[mass]]
| style="padding: 5px 5px; background: #F5F5F5;" |
* Chemotherapy: except those with stage 1a, stage 1a, 1b [[dysgerminoma]]
* Radiotherapy:
<nowiki>**</nowiki>  [[Dysgerminoma]] is radiosensitive.
[[Radiotherapy|** Radiotherapy]] is not anymore the first option of treatment for [[dysgerminoma]] considering its association with [[ovarian failure]]<nowiki/>development.
* Surgery: for diagnostic grading and therapy depending on if the patient prefers to preserve the ovary or not.
<br />
|-
| rowspan="6;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | Germinomatous/
Differentiated
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | Embryonic
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
Teratoma
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Chest pain]]
*[[Cough]]
*[[Shortness of breath]]
*[[Abdominal pain]]
*[[Lump]], Abdominal(ovarian teratoma)
* Abnormal [[bleeding]] from the vagina
*[[Fatigue]], [[weight loss]]
* Limited ability to tolerate exercise
| style="padding: 5px 5px; background: #F5F5F5;" |
* Teratomas belong to a class of tumors known as [[Nonseminoma|nonseminomatous]] [[germ cell tumor]] (NSGCT).
* All tumors of this class are the result of abnormal development of [[pluripotent]] cells: [[Germ cell|germ cells]] and [[Embryo|embryonal cells]].
* Teratomas of embryonal origin are [[Congenital disorder|congenital]]; teratomas of germ cell origin may or may not be congenital (this is not known).
* Embryonal teratomas most commonly occur in the sacrococcygeal region: [[sacrococcygeal teratoma]] is the single most common tumor found in [[Infant|newborn babies]].
| style="padding: 5px 5px; background: #F5F5F5;" |
* AFP
* MSAFP
* CT scans are often used to diagnose teratoma.
<br />
| style="padding: 5px 5px; background: #F5F5F5;" |
* For malignant teratomas, usually, surgery is followed by chemotherapy.
* Teratomas that are in surgically inaccessible locations, or are very complex, or are likely to be malignant (due to late discovery and/or treatment) sometimes are treated first with chemotherapy.
|-
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |
Extraembryonic
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
[[Choriocarcinoma]]([[Gestational Trophoblastic Neoplasia]])<ref name="xxx2">Signs and symptoms of gestational trophoblastic disease. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/gestational-trophoblastic-disease/signs-and-symptoms/?region=ns Accessed on October 10, 2015</ref><ref name="OberEdgcomb19712">{{cite journal|last1=Ober|first1=William B.|last2=Edgcomb|first2=John H.|last3=Price|first3=Edward B.|title=THE PATHOLOGY OF CHORIOCARCINOMA|journal=Annals of the New York Academy of Sciences|volume=172|issue=10 Physiology a|year=1971|pages=299–426|issn=0077-8923|doi=10.1111/j.1749-6632.1971.tb34943.x}}</ref><ref name="SmithKohorn20052">{{cite journal|last1=Smith|first1=Harriet O.|last2=Kohorn|first2=Ernest|last3=Cole|first3=Laurence A.|title=Choriocarcinoma and Gestational Trophoblastic Disease|journal=Obstetrics and Gynecology Clinics of North America|volume=32|issue=4|year=2005|pages=661–684|issn=08898545|doi=10.1016/j.ogc.2005.08.001}}</ref><ref name="abc3">Cellular Classification of Gestational Trophoblastic Disease. National Cancer Institute. http://www.cancer.gov/types/gestational-trophoblastic/hp/gtd-treatment-pdq/#section/_5 Accessed on October 8, 2015</ref><ref name="pmid62002622">{{cite journal |vauthors=Young RH, Scully RE |title=Placental-site trophoblastic tumor: current status |journal=Clin Obstet Gynecol |volume=27 |issue=1 |pages=248–58 |date=March 1984 |pmid=6200262 |doi= |url=}}</ref><ref name="pmid171499672">{{cite journal |vauthors=Allison KH, Love JE, Garcia RL |title=Epithelioid trophoblastic tumor: review of a rare neoplasm of the chorionic-type intermediate trophoblast |journal=Arch. Pathol. Lab. Med. |volume=130 |issue=12 |pages=1875–7 |date=December 2006 |pmid=17149967 |doi=10.1043/1543-2165(2006)130[1875:ETTROA]2.0.CO;2 |url=}}</ref><ref name="abc4">Diagnosing gestational trophoblastic disease. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/gestational-trophoblastic-disease/diagnosis/?region=ns Accessed on October 13, 2015</ref><ref name="aaa">Choriocarcinoma. librepathology.org. http://librepathology.org/wiki/index.php/Choriocarcinoma Accessed on October 8, 2015</ref>
| style="padding: 5px 5px; background: #F5F5F5;" |Early Symptoms:
*[[Vaginal bleeding]]
*[[Nausea]] and [[vomiting]]
*Passing of [[Tissue (biology)|tissue]] resembling a “bunch of grapes” from the [[vagina]]
*Absent [[fetal]] movement during [[pregnancy]]
*[[Abdomen|Abdominal]] distension 
Rare Symptoms:
*[[Headache]]
*[[Edema ]]of the [[Hand|hands]] and feet
*[[Abdomen|Abdominal]] or [[Pelvis|pelvic]] pain
*[[Vaginal discharge]]
*Overactive [[thyroid gland]] ([[hyperthyroidism]]) that causes:
*[[Tachycardia]]
*[[Sweating]]
*Shaking
*Heat intolerance
*[[Fever]]
Late Symptoms
*[[Hemoptysis]]
*Dry [[cough]]
*[[Chest pain]]
*Trouble [[breathing]]
*[[Headache]]
*[[Dizziness]]
*[[Jaundice]]
*[[Paralysis]]
*[[Seizure]]
*[[Dysarthria]] and [[dysphasia]]
*[[Visual system|Vision]] problems
*[[Lump]] in the [[vagina]]
| style="padding: 5px 5px; background: #F5F5F5;" |[[Gross pathology|Gross pathological]]:
* Bulky, destructive mass with [[Bleeding|hemorrhage]] and [[necrosis]]
* Can be associated with deep [[Myometrium|myometrial]] invasion
[[Microscopic]] [[Histopathology|histopathological:]]
*Columns and sheets of [[Trophoblast|trophoblastic]] [[Tissue (biology)|tissue]] invading [[Uterus|uterine]] [[muscle]] and [[Blood vessel|blood vessels]]
*[[Syncytiotrophoblast|Syncytiotrophoblasts]] (large [[eosinophilic]] smudgy [[Multinucleate|multinucleated]] [[Cell (biology)|cells]] with large [[Hyperchromicity|hyperchromatic]] [[Cell nucleus|nuclei]]) are intermixed with [[Cytotrophoblast|cytotrophoblasts]] (polygonal [[Cell (biology)|cells]] with distinct borders, and single irregular [[Cell nucleus|nuclei]])
<br />
| style="padding: 5px 5px; background: #F5F5F5;" |[[Human chorionic gonadotropin]] (HCG or b-HCG) is the most common [[tumor]] marker test used to diagnose GTD
HCG is markedly elevated (usu. >10,000 IU
*Human placental lactogen (hPL) is a tumor marker that may be used to follow women with placental site [[trophoblastic]] tumors
* Elevated hPL levels are found in women with some types of GTD
*[[Complete blood count]] can check for [[anemia]] from long-term (chronic) [[vaginal bleeding]]
<br />
| style="padding: 5px 5px; background: #F5F5F5;" |
Poor [[prognosis]] of gestational trophoblastic neoplasia (GTN) can be determined by the following factors:
* Age over 35 years ([[P-value|P]] = 0.025)
* Interval since the last [[pregnancy]] of over 2 years ([[P-value|P]] = 0.014)
* Deep [[Myometrium|myometrial]] invasion ([[P-value|P]] = 0.006)
* Stage III or IV ([[P-value|P]] < 0.0005)
* Maximum [[Human chorionic gonadotropin|βhCG]] level > 1000 mIU/ml ([[P-value|P]] = 0.034)
* Extensive [[coagulative necrosis]] ([[P-value|P]] = 0.024)
* High [[Mitosis|mitotic]] rate ([[P-value|P]] = 0.005)
* Presence of [[Cell (biology)|cells]] with clear [[cytoplasm]] ([[P-value|P]] < 0.0005)
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
[[Yolk sac tumor]]
(Endodermal sinus tumor)
| style="padding: 5px 5px; background: #F5F5F5;" |Symptoms:<ref name="www">{{cite book | last = Hoffman | first = Barbara | title = Williams gynecology | publisher = McGraw-Hill Medical | location = New York | year = 2012 | isbn = 9780071716727 }}</ref><ref name="pmid6185892">{{cite journal| author=Gershenson DM, Del Junco G, Herson J, Rutledge FN| title=Endodermal sinus tumor of the ovary: the M. D. Anderson experience. | journal=Obstet Gynecol | year= 1983 | volume= 61 | issue= 2 | pages= 194-202 | pmid=6185892 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6185892  }}</ref>
*[[Abdominal distention]]
* Acute/sub acute [[abdominal pain]]
*Signs:<ref name="abc2">{{cite book | last = Hoffman | first = Barbara | title = Williams gynecology | publisher = McGraw-Hill Medical | location = New York | year = 2012 | isbn = 9780071716727 }}</ref>
* Abdomen:
**[[Abdominal distention]]
** Abdominal [[tenderness]]
** Pelvis:
** Adnexal mass  <br />
<br />
| style="padding: 5px 5px; background: #F5F5F5;" |
** On gross [[pathology]]:
** Encaptulated, firm, smooth, round, globular, solid gray-white with a gelatinous, myxoid, or mucoid appearance, [[necrosis]], [[cystic]] changes, and [[hemorrhage]] are characteristic findings of endodermal sinus tumor.
** On microscopic [[histopathological]] analysis:
** Schiller-Duval bodies (invaginated papillary structures with central vessel) is a characteristic finding of endodermal sinus tumor. The [[tumors]] are composed of irregular space lined by flattened to cuboidal cells and recticular stroma
| style="padding: 5px 5px; background: #F5F5F5;" |
* An elevated concentration of serum alpha feto-protein is diagnostic of endodermal sinus tumor. <ref name="pmid6155988">{{cite journal| author=Talerman A, Haije WG, Baggerman L| title=Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: correlation between endodermal sinus (yolk sac) tumor and raised serum AFP. | journal=Cancer | year= 1980 | volume= 46 | issue= 2 | pages= 380-5 | pmid=6155988 | doi=10.1002/1097-0142(19800715)46:2<380::aid-cncr2820460228>3.0.co;2-u | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6155988  }}</ref>
* AFP is very important for diagnosis, disease monitoring and early metastasis
* Endodermal sinus tumor may also be diagnosed using biopsy and measurement of  GATA-4, a [[transcription factor]]<ref name="pmid10595911">{{cite journal| author=Siltanen S, Anttonen M, Heikkilä P, Narita N, Laitinen M, Ritvos O et al.| title=Transcription factor GATA-4 is expressed in pediatric yolk sac tumors. | journal=Am J Pathol | year= 1999 | volume= 155 | issue= 6 | pages= 1823-9 | pmid=10595911 | doi=10.1016/S0002-9440(10)65500-9 | pmc=1866939 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10595911  }}</ref>
*
| style="padding: 5px 5px; background: #F5F5F5;" |
*Endodermal sinus tumor has a poor [[prognosis]] in [[adult]].<ref name="pmid12432104">{{cite journal| author=Jung SE, Lee JM, Rha SE, Byun JY, Jung JI, Hahn ST| title=CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. | journal=Radiographics | year= 2002 | volume= 22 | issue= 6 | pages= 1305-25 | pmid=12432104 | doi=10.1148/rg.226025033 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12432104  }}</ref><ref name="pmid18063508">{{cite journal| author=Hung JH, Shen SH, Hung J, Lai CR| title=Ultrasound and magnetic resonance images of endodermal sinus tumor. | journal=J Chin Med Assoc | year= 2007 | volume= 70 | issue= 11 | pages= 514-8 | pmid=18063508 | doi=10.1016/S1726-4901(08)70052-2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18063508  }}</ref>
*Endodermal sinus tumor has a favorable [[prognosis]] in [[children]].<ref name="pmid12875960">{{cite journal| author=Kato N, Tamura G, Fukase M, Shibuya H, Motoyama T| title=Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants. | journal=Am J Pathol | year= 2003 | volume= 163 | issue= 2 | pages= 387-91 | pmid=12875960 | doi=10.1016/S0002-9440(10)63668-1 | pmc=1868235 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12875960  }}</ref>
*Endodermal sinus tumor is the most common [[malignant germ cell tumor]] in [[children]].<ref name="pmid12432104">{{cite journal| author=Jung SE, Lee JM, Rha SE, Byun JY, Jung JI, Hahn ST| title=CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. | journal=Radiographics | year= 2002 | volume= 22 | issue= 6 | pages= 1305-25 | pmid=12432104 | doi=10.1148/rg.226025033 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12432104  }} </ref><ref name="urlDefinition of endodermal sinus tumor - NCI Dictionary of Cancer Terms - National Cancer Institute">{{cite web |url=https://www.cancer.gov/publications/dictionaries/cancer-terms/def/791307 |title=Definition of endodermal sinus tumor - NCI Dictionary of Cancer Terms - National Cancer Institute |format= |work= |accessdate=}}</ref>
*If left untreated, endodermal sinus tumor quickly [[Metastasize|metastasizes]] in other parts of the [[body]] such as the [[brain]].<ref name="urlDefinition of endodermal sinus tumor - NCI Dictionary of Cancer Terms - National Cancer Institute">{{cite web |url=https://www.cancer.gov/publications/dictionaries/cancer-terms/def/791307 |title=Definition of endodermal sinus tumor - NCI Dictionary of Cancer Terms - National Cancer Institute |format= |work= |accessdate=}}</ref>
* Endodermal sinus tumor can be found in the [[ovaries]] or [[testicles]] including the [[chest]], [[abdomen]], and the [[brain]].<ref name="urlDefinition of endodermal sinus tumor - NCI Dictionary of Cancer Terms - National Cancer Institute">{{cite web |url=https://www.cancer.gov/publications/dictionaries/cancer-terms/def/791307 |title=Definition of endodermal sinus tumor - NCI Dictionary of Cancer Terms - National Cancer Institute |format= |work= |accessdate=}}</ref>
*[[Ovarian germ cell tumor|Ovarian germ cell tumo]]<nowiki/>r (endodermal sinus tumor) is surgically staged using the [[International Federation of Gynecology and Obstetrics|FIGO]] [[cancer staging]] system:<ref name="mmm">Stage Information for Ovarian Germ Cell Tumors. http://www.cancer.gov/types/ovarian/hp/ovarian-germ-cell-treatment-pdq#section/_8. URL Accessed on November 5, 2015</ref>
|-
|}


==[[Germ cell tumor causes|Causes]]==
==[[Germ cell tumor causes|Causes]]==
*The cause of germ cell tumor is not understood fully but there are many risk factors that believed to play a role in the development of germ cell tumors.
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Germ cell tumor}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|causes}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1|General Causes
| style="padding: 5px 5px; background: #F5F5F5;" |
*
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1|Dysgerminoma
| style="padding: 5px 5px; background: #F5F5F5;" |
*
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1|Seminoma
| style="padding: 5px 5px; background: #F5F5F5;" |Common causes
*[[Cryptorchidism]]
* Undescended testis
* Abdominal testis
* Trauma
* Mumps
* Maternal estrogen exposure
* Genetic Causes
* Seminoma is caused by a mutation in the KIT gene.
* 12p11.2-p12.1 chromosomal amplifications and deletions observed in majority of cases.
<br />
*
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1|Embryonal cell carcinoma
| style="padding: 5px 5px; background: #F5F5F5;" |
*
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1|Choriocarcinoma
| style="padding: 5px 5px; background: #F5F5F5;" |
* Abnormal [[Trophoblast|trophoblastic]] population undergoing [[hyperplasia]] and [[anaplasia]] can give rise to [[choriocarcinoma]].
* [[Gestation|Gestational]] type arises following a [[hydatidiform mole]], normal [[pregnancy]], or most commonly, abortion.
* Non-[[Gestation|gestational]] type arises from [[Pluripotency|pluripotent]] [[Germ cell|germ cells]].
*
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1|Yolk sac tumor
| style="padding: 5px 5px; background: #F5F5F5;" |
*
|-
The etiology of yolk sac tumors (YSTs) is essentially unknown. It is speculated that hypermethylation of the RUNX3 gene promoter and overexpression of GATA-4, a transcription factor that regulates differentiation and function of yolk sac endoderm, may play important roles in the pathogenesis of yolk sac tumors (YSTs)
|-
|}


==[[Germ cell tumor risk factors|Risk Factors]]==
==[[Germ cell tumor risk factors|Risk Factors]]==
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Germ cell tumor}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Risk factors}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Ovarian germ cell tumor<ref name="PleskacovaHersmus20102">{{cite journal|last1=Pleskacova|first1=J.|last2=Hersmus|first2=R.|last3=Oosterhuis|first3=J.W.|last4=Setyawati|first4=B.A.|last5=Faradz|first5=S.M.|last6=Cools|first6=M.|last7=Wolffenbuttel|first7=K.P.|last8=Lebl|first8=J.|last9=Drop|first9=S.L.|last10=Looijenga|first10=L.H.|title=Tumor Risk in Disorders of Sex Development|journal=Sexual Development|volume=4|issue=4-5|year=2010|pages=259–269|issn=1661-5433|doi=10.1159/000314536}}</ref><ref name="SharpeSkakkebaek20082">{{cite journal|last1=Sharpe|first1=Richard M.|last2=Skakkebaek|first2=Niels E.|title=Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects|journal=Fertility and Sterility|volume=89|issue=2|year=2008|pages=e33–e38|issn=00150282|doi=10.1016/j.fertnstert.2007.12.026}}</ref><ref name="SkakkebækRajpert-De Meyts20012">{{cite journal|last1=Skakkebæk|first1=N.E.|last2=Rajpert-De Meyts|first2=E.|last3=Main|first3=K.M.|title=Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects: Opinion|journal=Human Reproduction|volume=16|issue=5|year=2001|pages=972–978|issn=1460-2350|doi=10.1093/humrep/16.5.972}}</ref><ref name="pmid33903782">{{cite journal |vauthors=Walker AH, Ross RK, Haile RW, Henderson BE |title=Hormonal factors and risk of ovarian germ cell cancer in young women |journal=Br. J. Cancer |volume=57 |issue=4 |pages=418–22 |date=April 1988 |pmid=3390378 |pmc=2246577 |doi= |url=}}</ref><ref name="pmid190387642">{{cite journal |vauthors=Hackethal A, Brueggmann D, Bohlmann MK, Franke FE, Tinneberg HR, Münstedt K |title=Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data |journal=Lancet Oncol. |volume=9 |issue=12 |pages=1173–80 |date=December 2008 |pmid=19038764 |doi=10.1016/S1470-2045(08)70306-1 |url=}}</ref><ref name="ParkKim20082">{{cite journal|last1=Park|first1=Jeong-Yeol|last2=Kim|first2=Dae-Yeon|last3=Kim|first3=Jong-Hyeok|last4=Kim|first4=Yong-Man|last5=Kim|first5=Young-Tak|last6=Nam|first6=Joo-Hyun|title=Malignant transformation of mature cystic teratoma of the ovary: Experience at a single institution|journal=European Journal of Obstetrics & Gynecology and Reproductive Biology|volume=141|issue=2|year=2008|pages=173–178|issn=03012115|doi=10.1016/j.ejogrb.2008.07.032}}</ref><ref name="wqd2">{{cite book | last = Kliegman | first = Robert | title = Nelson textbook of pediatrics | publisher = Elsevier/Saunders | location = Philadelphia, PA | year = 2011 | isbn = 978-1-4377-0755-7 }}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[gonadal dysgenesis]]
*[[Maternal]] [[hormonal]] factors:
**[[Maternal]] high [[body mass index]]
** Maternal use of exogenous [[hormones]]
*Other [[reproductive]] factors:
**[[Parity]]
**[[Oral contraceptive]] use
**Age at first and last births 
Dysgerminoma:
*[[gonadal dysgenesis]],
*[[androgen insensitivity syndrome]]
*[[gonadoblastoma]].<br />
*
Mature teratoma:
Common risk factors in the malignant transformation of mature teratoma include:
*Old age (> 50 years old)
*Large tumor size (> 10 cm)
*Presence of a solid portion
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;" | Seminoma<ref name="riskfactorsfortesticulargermcelltumotrssnkjb2">Risk factors for testicular germ cell tumors. Dr Matt A. Morgan and Dr Andrew Dixon et al. Radiopaedia 2016. Accessed on February 25, 2016</ref><ref name="seminomariskfactorsmlmn12">Causes of seminoma. US National Library of Medicine 2016. https://www.nlm.nih.gov/medlineplus/ency/article/001288.htm. Accessed on February 29, 2016</ref><ref name="pmid179168702">{{cite journal |vauthors=Khan O, Protheroe A |title=Testis cancer |journal=Postgrad Med J |volume=83 |issue=984 |pages=624–32 |date=October 2007 |pmid=17916870 |pmc=2600126 |doi=10.1136/pgmj.2007.057992 |url=http://pmj.bmj.com/cgi/pmidlookup?view=long&pmid=17916870}}</ref><ref name="pmid225084592">{{cite journal |vauthors=McGlynn KA, Trabert B |title=Adolescent and adult risk factors for testicular cancer |journal=Nat Rev Urol |volume=9 |issue=6 |pages=339–49 |date=April 2012 |pmid=22508459 |pmc=4031676 |doi=10.1038/nrurol.2012.61 |url=}}</ref><ref name="pmid292626682">{{cite journal |vauthors=Boccellino M, Vanacore D, Zappavigna S, Cavaliere C, Rossetti S, D'Aniello C, Chieffi P, Amler E, Buonerba C, Di Lorenzo G, Di Franco R, Izzo A, Piscitelli R, Iovane G, Muto P, Botti G, Perdonà S, Caraglia M, Facchini G |title=Testicular cancer from diagnosis to epigenetic factors |journal=Oncotarget |volume=8 |issue=61 |pages=104654–104663 |date=November 2017 |pmid=29262668 |pmc=5732834 |doi=10.18632/oncotarget.20992 |url=}}</ref><ref name="pmid282411062">{{cite journal |vauthors=Ghazarian AA, Kelly SP, Altekruse SF, Rosenberg PS, McGlynn KA |title=Future of testicular germ cell tumor incidence in the United States: Forecast through 2026 |journal=Cancer |volume=123 |issue=12 |pages=2320–2328 |date=June 2017 |pmid=28241106 |pmc=5629636 |doi=10.1002/cncr.30597 |url=}}</ref><ref name="pmid265603142">{{cite journal |vauthors=Gurney J, Shaw C, Stanley J, Signal V, Sarfati D |title=Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis |journal=BMC Cancer |volume=15 |issue= |pages=897 |date=November 2015 |pmid=26560314 |pmc=4642772 |doi=10.1186/s12885-015-1905-6 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" |
Common Risk Factors
*Caucasian race
*[[Undescended testicle]]
*[[Family history]] of [[Testicle|testicular]] [[cancer]]
*Personal history of [[testicular cancer]]  (previous tumor in contralateral testis)
*[[Klinefelter syndrome]]
* Impaired [[spermatogenesis]]
*[[Hypospadias]]
*[[Testicular]] microlithiasis
*[[Testicular]] [[dysgenesis]]
*[[Testicular]] [[Feminization (biology)|feminization]]
*[[Klinefelter's Syndrome|Klinefelter syndrome]]
Less Common Risk Factors
*[[Infection|Infections]] such as [[HIV]], [[orchitis]]
*History of [[trauma]]
*[[Organ transplant]] [[immunosuppression]]
* Canabis exposure
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Embryonal carcinoma''' '''
| style="padding: 5px 5px; background: #F5F5F5;" |
*
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan=1;"|Teratoma''' '''
| style="padding: 5px 5px; background: #F5F5F5;" |
*
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Choriocarcinoma''' '''
| style="padding: 5px 5px; background: #F5F5F5;" |
*'''Maternal'''
*The risk of choriocarcinoma increases progressively in women older than 25 years
*The risk increases more rapidly in women older than 39 years
*The risk is higher for women younger than 20 compared with women aged 20 – 24 years
*History of Gestational Trophoblastic Disease
*Reproductive Factors
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Yolk sac tumor''' '''
| style="padding: 5px 5px; background: #F5F5F5;" |
*
|}


==Related chapters==
==Related chapters==
Line 48: Line 439:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
==References==
[[Category:Oncology]]
{{Reflist|2}}
[[Category:Medicine]]
[[Category:Gynecology]]
[[Category:Surgery]]

Latest revision as of 22:14, 16 September 2021


Template:DiseaseDisorder infobox

Germ Cell Tumors Microchapters

Patient Information

Overview

Classification

Dysgerminoma
Seminoma
Embryonal carcinoma
Teratoma
Choriocarcinoma
Yolk sac tumor

Causes

Risk Factors

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.

Synonyms and keywords: Polyembryoma;

Overview

A germ-cell tumor (GCT) is a neoplasm derived from germ cells and it can be cancerous or benign. Based on their location, germ cell tumors can be classified into intragonadal (ovary and testis) or extragonadal (mediastinum, brain, retroperitoneum, coccyx). Histologically, Germ cell tumors can be classified as germinomatous/undifferentiated germ cell tumors which include, dysgerminoma and seminoma. and nongermminomatous/differentiated which include embryonic and extra-embryonic germ cell tumors. Embryonic germ cell tumors include teratoma, and extraembryonic germ cell tumors include Choriocarcinoma and Yolk sac tumor. The name of a germ cell tumor came from the word (germinate), which means to begin to grow. During fetus development, germ cells migrate to become the eggs in the ovary or the sperms in the testicles. Germ cell tumors develop due to the abnormal growth of the germ cells in the ovary, testis, brain, mediastinum, coccyx, or pelvis. World health organization (WHO) classified germ cell tumors into 7 types based on histology. The cause of germ cell tumors development is not fully understood but some causes include, genetic mutations, cryptorchidism, undescended testes, trauma, mumps, maternal estrogen exposure. Common risk factors include Caucasian race,Family history or personal history of germ cell tumor, Klinefelter syndrome. Less common risk factors include,Infections such as HIV, orchitis, or history of trauma. Symptoms and signs of germ cell tumors depend on the type and location of the tumor. Symptoms of dysgerminoma can include, abdominal distention, acute/ subacute abdominal pain, menstrual irregularities, and precocious puberty. Symptoms of seminoma include painless testicular mass with discomfort, back pain, abdominal discomfort, or abdominal mass. Common complications of germ cell tumors include recurrence, lymph node metastasis, distant metastasis, and secondary malignancies. Lab findings include abnormal serum tumor marker levels such as LDH, HCG (seminoma), lactate dehydrogenase (LDH), human chorionic gonadotropin (HCG), CA-125, and alpha-fetoprotein (AFP) (ovarian germ cell tumors), alpha fetoprotein (AFP) greater than 100 ng/ml (Endodermal sinus tumor). CT, MRI, and ultrasound are used in combination with biopsy to distinguish between the types and subtypes of germ cell tumors and for diagnosis confirmation. Surgery along with chemotherapy are the mainstay of treatment depending on the staging of the tumor. Depending on the type, location, and the extent of the tumor at the time of diagnosis, the prognosis may vary.

Classification

Germ cell tumors can be classified as follows:

Histologic-based classification


 
 
 
 
 
 
 
 
 
Germ cell tumors
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Germinomatous/Undifferentiated/Immature
 
 
 
 
 
 
 
 
Nongerminomatous/Differentiated/Mature
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dysgerminoma(Ovary)
 
 
 
Seminoma(Testis)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Embryonal carcinoma
 
 
 
 
 
 
Embryonic tissue
 
 
 
 
Extraembryonic tissue
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Teratoma
 
 
Yolk sac tumor
 
Choriocarcinoma
 
 

Location-based classification, regardless to the histologic findings:


 
 
 
 
 
 
 
 
Germ cell tumors
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gonadal
 
 
 
 
 
 
 
 
Extragonadal
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Located in the gonads
 
 
 
 
 
 
 
 
Located in the midline of the body including:
  • CNS
  • Mediastinum
  • Retroperitoneum
  • Coccyx
  •  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     


    Types Subtypes Signs and Symptoms Histopathology Lab finding Prognosis
    Germinomatous

    /Undifferentiated

    Seminoma (Testis)

    Gross: pale gray to yellow nodules that are uniform or slightly lobulated and often bulge from the cut surface
    • Complete blood count and blood chemistry tests.
    • Abnormal serum tumor marker levels (LDH, HCG).
    • CT: Metastases to the para-aortic, inguinal, or iliac lymph nodes. Visceral metastasis may also be seen.
    • Pelvic MRI: may be diagnostic. multinodular tumors of uniform signal intensity
    • Hypo- to isointense on T2-weighted images and inhomogenous enhancement on contrast enhanced T1-weighted images.
    • Other diagnostic studies for seminoma include biopsy, FDG-PET scan, and bone scan.

    Dysgerminoma

    (Ovary)

    • Chemotherapy: except those with stage 1a, stage 1a, 1b dysgerminoma
    • Radiotherapy:

    ** Dysgerminoma is radiosensitive.

    ** Radiotherapy is not anymore the first option of treatment for dysgerminoma considering its association with ovarian failuredevelopment.

    • Surgery: for diagnostic grading and therapy depending on if the patient prefers to preserve the ovary or not.


    Germinomatous/

    Differentiated

    Embryonic

    Teratoma

    • AFP
    • MSAFP
    • CT scans are often used to diagnose teratoma.


    • For malignant teratomas, usually, surgery is followed by chemotherapy.
    • Teratomas that are in surgically inaccessible locations, or are very complex, or are likely to be malignant (due to late discovery and/or treatment) sometimes are treated first with chemotherapy.

    Extraembryonic

    Choriocarcinoma(Gestational Trophoblastic Neoplasia)[1][2][3][4][5][6][7][8]

    Early Symptoms:

    Rare Symptoms:

    Late Symptoms

    Gross pathological:

    Microscopic histopathological:


    Human chorionic gonadotropin (HCG or b-HCG) is the most common tumor marker test used to diagnose GTD

    HCG is markedly elevated (usu. >10,000 IU



    Poor prognosis of gestational trophoblastic neoplasia (GTN) can be determined by the following factors:

    Yolk sac tumor

    (Endodermal sinus tumor)

    Symptoms:[9][10]


      • On gross pathology:
      • Encaptulated, firm, smooth, round, globular, solid gray-white with a gelatinous, myxoid, or mucoid appearance, necrosis, cystic changes, and hemorrhage are characteristic findings of endodermal sinus tumor.
      • On microscopic histopathological analysis:
      • Schiller-Duval bodies (invaginated papillary structures with central vessel) is a characteristic finding of endodermal sinus tumor. The tumors are composed of irregular space lined by flattened to cuboidal cells and recticular stroma
    • An elevated concentration of serum alpha feto-protein is diagnostic of endodermal sinus tumor. [12]
    • AFP is very important for diagnosis, disease monitoring and early metastasis
    • Endodermal sinus tumor may also be diagnosed using biopsy and measurement of GATA-4, a transcription factor[13]


    Causes

    • The cause of germ cell tumor is not understood fully but there are many risk factors that believed to play a role in the development of germ cell tumors.
    The etiology of yolk sac tumors (YSTs) is essentially unknown. It is speculated that hypermethylation of the RUNX3 gene promoter and overexpression of GATA-4, a transcription factor that regulates differentiation and function of yolk sac endoderm, may play important roles in the pathogenesis of yolk sac tumors (YSTs)
    Germ cell tumor causes
    General Causes
    Dysgerminoma
    Seminoma Common causes
    • Cryptorchidism
    • Undescended testis
    • Abdominal testis
    • Trauma
    • Mumps
    • Maternal estrogen exposure
    • Genetic Causes
    • Seminoma is caused by a mutation in the KIT gene.
    • 12p11.2-p12.1 chromosomal amplifications and deletions observed in majority of cases.


    Embryonal cell carcinoma
    Choriocarcinoma
    Yolk sac tumor


    Risk Factors

    Germ cell tumor Risk factors
    Ovarian germ cell tumor[19][20][21][22][23][24][25]

    Dysgerminoma:

    Mature teratoma: Common risk factors in the malignant transformation of mature teratoma include:

    • Old age (> 50 years old)
    • Large tumor size (> 10 cm)
    • Presence of a solid portion
    Seminoma[26][27][28][29][30][31][32]

    Common Risk Factors

    Less Common Risk Factors

    Embryonal carcinoma
    Teratoma
    Choriocarcinoma
    • Maternal
    • The risk of choriocarcinoma increases progressively in women older than 25 years
    • The risk increases more rapidly in women older than 39 years
    • The risk is higher for women younger than 20 compared with women aged 20 – 24 years
    • History of Gestational Trophoblastic Disease
    • Reproductive Factors
    Yolk sac tumor

    Related chapters

    External Links


    Template:WikiDoc Sources

    References

    1. Signs and symptoms of gestational trophoblastic disease. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/gestational-trophoblastic-disease/signs-and-symptoms/?region=ns Accessed on October 10, 2015
    2. Ober, William B.; Edgcomb, John H.; Price, Edward B. (1971). "THE PATHOLOGY OF CHORIOCARCINOMA". Annals of the New York Academy of Sciences. 172 (10 Physiology a): 299–426. doi:10.1111/j.1749-6632.1971.tb34943.x. ISSN 0077-8923.
    3. Smith, Harriet O.; Kohorn, Ernest; Cole, Laurence A. (2005). "Choriocarcinoma and Gestational Trophoblastic Disease". Obstetrics and Gynecology Clinics of North America. 32 (4): 661–684. doi:10.1016/j.ogc.2005.08.001. ISSN 0889-8545.
    4. Cellular Classification of Gestational Trophoblastic Disease. National Cancer Institute. http://www.cancer.gov/types/gestational-trophoblastic/hp/gtd-treatment-pdq/#section/_5 Accessed on October 8, 2015
    5. Young RH, Scully RE (March 1984). "Placental-site trophoblastic tumor: current status". Clin Obstet Gynecol. 27 (1): 248–58. PMID 6200262.
    6. Allison KH, Love JE, Garcia RL (December 2006). "Epithelioid trophoblastic tumor: review of a rare neoplasm of the chorionic-type intermediate trophoblast". Arch. Pathol. Lab. Med. 130 (12): 1875–7. doi:10.1043/1543-2165(2006)130[1875:ETTROA]2.0.CO;2. PMID 17149967.
    7. Diagnosing gestational trophoblastic disease. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/gestational-trophoblastic-disease/diagnosis/?region=ns Accessed on October 13, 2015
    8. Choriocarcinoma. librepathology.org. http://librepathology.org/wiki/index.php/Choriocarcinoma Accessed on October 8, 2015
    9. Hoffman, Barbara (2012). Williams gynecology. New York: McGraw-Hill Medical. ISBN 9780071716727.
    10. Gershenson DM, Del Junco G, Herson J, Rutledge FN (1983). "Endodermal sinus tumor of the ovary: the M. D. Anderson experience". Obstet Gynecol. 61 (2): 194–202. PMID 6185892.
    11. Hoffman, Barbara (2012). Williams gynecology. New York: McGraw-Hill Medical. ISBN 9780071716727.
    12. Talerman A, Haije WG, Baggerman L (1980). "Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: correlation between endodermal sinus (yolk sac) tumor and raised serum AFP". Cancer. 46 (2): 380–5. doi:10.1002/1097-0142(19800715)46:2<380::aid-cncr2820460228>3.0.co;2-u. PMID 6155988.
    13. Siltanen S, Anttonen M, Heikkilä P, Narita N, Laitinen M, Ritvos O; et al. (1999). "Transcription factor GATA-4 is expressed in pediatric yolk sac tumors". Am J Pathol. 155 (6): 1823–9. doi:10.1016/S0002-9440(10)65500-9. PMC 1866939. PMID 10595911.
    14. 14.0 14.1 Jung SE, Lee JM, Rha SE, Byun JY, Jung JI, Hahn ST (2002). "CT and MR imaging of ovarian tumors with emphasis on differential diagnosis". Radiographics. 22 (6): 1305–25. doi:10.1148/rg.226025033. PMID 12432104.
    15. Hung JH, Shen SH, Hung J, Lai CR (2007). "Ultrasound and magnetic resonance images of endodermal sinus tumor". J Chin Med Assoc. 70 (11): 514–8. doi:10.1016/S1726-4901(08)70052-2. PMID 18063508.
    16. Kato N, Tamura G, Fukase M, Shibuya H, Motoyama T (2003). "Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants". Am J Pathol. 163 (2): 387–91. doi:10.1016/S0002-9440(10)63668-1. PMC 1868235. PMID 12875960.
    17. 17.0 17.1 17.2 "Definition of endodermal sinus tumor - NCI Dictionary of Cancer Terms - National Cancer Institute".
    18. Stage Information for Ovarian Germ Cell Tumors. http://www.cancer.gov/types/ovarian/hp/ovarian-germ-cell-treatment-pdq#section/_8. URL Accessed on November 5, 2015
    19. Pleskacova, J.; Hersmus, R.; Oosterhuis, J.W.; Setyawati, B.A.; Faradz, S.M.; Cools, M.; Wolffenbuttel, K.P.; Lebl, J.; Drop, S.L.; Looijenga, L.H. (2010). "Tumor Risk in Disorders of Sex Development". Sexual Development. 4 (4–5): 259–269. doi:10.1159/000314536. ISSN 1661-5433.
    20. Sharpe, Richard M.; Skakkebaek, Niels E. (2008). "Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects". Fertility and Sterility. 89 (2): e33–e38. doi:10.1016/j.fertnstert.2007.12.026. ISSN 0015-0282.
    21. Skakkebæk, N.E.; Rajpert-De Meyts, E.; Main, K.M. (2001). "Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects: Opinion". Human Reproduction. 16 (5): 972–978. doi:10.1093/humrep/16.5.972. ISSN 1460-2350.
    22. Walker AH, Ross RK, Haile RW, Henderson BE (April 1988). "Hormonal factors and risk of ovarian germ cell cancer in young women". Br. J. Cancer. 57 (4): 418–22. PMC 2246577. PMID 3390378.
    23. Hackethal A, Brueggmann D, Bohlmann MK, Franke FE, Tinneberg HR, Münstedt K (December 2008). "Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data". Lancet Oncol. 9 (12): 1173–80. doi:10.1016/S1470-2045(08)70306-1. PMID 19038764.
    24. Park, Jeong-Yeol; Kim, Dae-Yeon; Kim, Jong-Hyeok; Kim, Yong-Man; Kim, Young-Tak; Nam, Joo-Hyun (2008). "Malignant transformation of mature cystic teratoma of the ovary: Experience at a single institution". European Journal of Obstetrics & Gynecology and Reproductive Biology. 141 (2): 173–178. doi:10.1016/j.ejogrb.2008.07.032. ISSN 0301-2115.
    25. Kliegman, Robert (2011). Nelson textbook of pediatrics. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1-4377-0755-7.
    26. Risk factors for testicular germ cell tumors. Dr Matt A. Morgan and Dr Andrew Dixon et al. Radiopaedia 2016. Accessed on February 25, 2016
    27. Causes of seminoma. US National Library of Medicine 2016. https://www.nlm.nih.gov/medlineplus/ency/article/001288.htm. Accessed on February 29, 2016
    28. Khan O, Protheroe A (October 2007). "Testis cancer". Postgrad Med J. 83 (984): 624–32. doi:10.1136/pgmj.2007.057992. PMC 2600126. PMID 17916870.
    29. McGlynn KA, Trabert B (April 2012). "Adolescent and adult risk factors for testicular cancer". Nat Rev Urol. 9 (6): 339–49. doi:10.1038/nrurol.2012.61. PMC 4031676. PMID 22508459.
    30. Boccellino M, Vanacore D, Zappavigna S, Cavaliere C, Rossetti S, D'Aniello C, Chieffi P, Amler E, Buonerba C, Di Lorenzo G, Di Franco R, Izzo A, Piscitelli R, Iovane G, Muto P, Botti G, Perdonà S, Caraglia M, Facchini G (November 2017). "Testicular cancer from diagnosis to epigenetic factors". Oncotarget. 8 (61): 104654–104663. doi:10.18632/oncotarget.20992. PMC 5732834. PMID 29262668.
    31. Ghazarian AA, Kelly SP, Altekruse SF, Rosenberg PS, McGlynn KA (June 2017). "Future of testicular germ cell tumor incidence in the United States: Forecast through 2026". Cancer. 123 (12): 2320–2328. doi:10.1002/cncr.30597. PMC 5629636. PMID 28241106.
    32. Gurney J, Shaw C, Stanley J, Signal V, Sarfati D (November 2015). "Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis". BMC Cancer. 15: 897. doi:10.1186/s12885-015-1905-6. PMC 4642772. PMID 26560314.